Dnmt3a restrains mast cell inflammatory responses

Cristina Leoni1,2, Sara Montagner1, Andrea Rinaldi3

  • 1Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500 Bellinzona, Switzerland.

Insights

DNA methyltransferase DNMT3A restrains mast cell responses. Loss of DNMT3A or DNA methylation enhances mast cell activation, impacting hematological diseases and immune cell function.

Area of Science:

  • Immunology
  • Epigenetics
  • Molecular Biology

Background:

  • DNA methylation and DNMT3A are implicated in hematological diseases and immune cell regulation.
  • Altered DNA methylation and DNMT3A mutations correlate with mast cell disorders, but its role in mast cell biology is unclear.

Purpose of the Study:

  • To investigate the role of DNA methylation, specifically the enzyme DNMT3A, in mast cell biology and responsiveness.
  • To elucidate the mechanisms underlying DNMT3A's function in mast cell activation.

Main Methods:

  • Utilized mast cells genetically deficient in Dnmt3a.
  • Assessed mast cell responses in vitro and in vivo.
  • Investigated effects of demethylating agents (5-aza-2'-deoxycytidine) and Dnmt1 expression modulation.
  • Analyzed the expression of the scaffold protein IQGAP2.

Main Results:

  • Dnmt3a-deficient mast cells exhibit heightened responses to acute and chronic stimuli.
  • Exacerbated mast cell responses were replicated by demethylating agents and Dnmt1 downregulation.
  • These effects are partly mediated by dysregulated IQGAP2 expression.

Conclusions:

  • DNMT3A and DNA methylation are critical regulators of mast cell responsiveness.
  • DNMT3A plays a key role in restraining mast cell activation to various stimuli.
  • Findings contribute to understanding mast cell biology in hematological diseases and immune function.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.6K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.2K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.6K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K